![Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records | British Journal of Cancer Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-019-0458-x/MediaObjects/41416_2019_458_Fig1_HTML.png)
Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records | British Journal of Cancer
![PDF) Tumor Markers CA 125 and CA 19–9 in Cord Blood and During Infancy: Developmental Changes and Use in Pediatric Germ Cell Tumors | Pentti Kuusela - Academia.edu PDF) Tumor Markers CA 125 and CA 19–9 in Cord Blood and During Infancy: Developmental Changes and Use in Pediatric Germ Cell Tumors | Pentti Kuusela - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/43309268/mini_magick20190216-8790-1xmnwfe.png?1550330564)
PDF) Tumor Markers CA 125 and CA 19–9 in Cord Blood and During Infancy: Developmental Changes and Use in Pediatric Germ Cell Tumors | Pentti Kuusela - Academia.edu
![Frontiers | Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers Frontiers | Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers](https://www.frontiersin.org/files/MyHome%20Article%20Library/566511/566511_Thumb_400.jpg)
Frontiers | Tumor-Associated Macrophages in Human Breast, Colorectal, Lung, Ovarian and Prostate Cancers
![Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332221012749-ga1.jpg)
Current advances in prognostic and diagnostic biomarkers for solid cancers: Detection techniques and future challenges - ScienceDirect
![Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-65720-8/MediaObjects/41598_2020_65720_Fig1_HTML.png)
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
![Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13048-020-00681-0/MediaObjects/13048_2020_681_Fig3_HTML.png)
Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer | Journal of Ovarian Research | Full Text
![Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/ad4f7df5-b2d3-4fe9-87d0-d22547326edf/gr1.gif)
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study - The Lancet Oncology
MEMORANDUM #135 TO: FROM: Herbert C. Whinna, MD, PhD Interim Director, Core Laboratories Medical Director, McLendon Clinical Lab
![The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt-2020-0015/asset/images/medium/figure2.gif)
The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer | Breast Cancer Management
![Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting](https://www.frontiersin.org/files/MyHome%20Article%20Library/479117/479117_Thumb_400.jpg)
Frontiers | Diagnostic Tumor Markers in Head and Neck Squamous Cell Carcinoma (HNSCC) in the Clinical Setting
![A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003269718304263-fx1.jpg)